The Globe and Mail reports in its Thursday edition that CIBC World Markets analyst Mark Jarvi has reaffirmed his "outperformer" call on Boralex. The Globe's David Leeder writes that Mr. Jarvi lowered his share target by a loonie to $37. Analysts on average target the shares at $36. Mr. Jarvi says in a note: "Boralex suffered through an uninspiring 2025. U.S. policy uncertainty clouded most renewable stocks and then once momentum turned more positive, Boralex's quarterly results and announcements skewed negative (CFO departure, no hydro asset sales, commissioning delays). We believe 2026 can bring more positive news on development with multiple RFP announcements to come that could solidify its growth path to 2030. Further, Boralex should lap easier comparables next year and we have the company generating some of the strongest year-over-year growth in our coverage. On valuation, the stock is very attractive trading at a 30-per-cent discount to our NAV (highest in our coverage). We believe the quality of its assets/team and the growth will ultimately reward investors." The Globe reported on July 23, 2024, and Jan. 9, 2025, that Mr. Jarvi had reaffirmed his "outperformer" call on Boralex. It was then worth $33.10 and $27.40.